News

A Patent Analytics Study on the Australian Advanced Manufacturing Industry

Executive summary Innovation is critical in developing new avenues for economic growth and prosperity for Australia. Innovation can take many different forms and is consequently used and produced by many different businesses. In 2013-14, the manufacturing sector accounted…

2017 Connecting Women – Charity Announced!

The BioMelbourne Network Connecting Women Lunch is now fully booked with over 400 women set to attend on Friday 2nd June. We’re also delighted that we have received a record number of nominations for the BioMelbourne Network Women in Leadership…

More Access To Life-Changing Genomic Testing For Rare Diseases

More Victorian children with rare conditions and diseases will now be able to access world-leading genomic sequencing tests – at no cost – so they can get the diagnosis and treatment they need sooner. The Andrews Labor Government…

New 4D Scanners Give A Clearer Picture Of Lung Health

A world-first scanner – manufactured right here in Victoria – will provide four-dimensional respiratory analysis to better diagnose and treat lung conditions. Visiting Monash University in Clayton today, Minister for Industry and Employment Wade Noonan was given a…

Joint statement on the Research & Development Tax Incentive 18 April 2017

Don’t rip the guts out of Australian medical research commercialisation Commercialisation of Australian medical research is under serious threat if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the Research & Development (R&D) Tax…

Westpac Businesses of Tomorrow 2017 – Trajan Scientific and Medical Top 20

Right from our very beginning in 1817, Westpac has been guided by the same purpose: TO SUPPORT THE ECONOMIC PROGRESS OF AUSTRALIAN BUSINESSES. As we reach our 200th anniversary, that guiding purpose remains. To help the next generation…

Australia’s ProTA accelerates the development of immunotherapy to treat peanut allergy

Allergy immunotherapy company ProTA Therapeutics Pty Ltd (ProTA) will accelerate the development of a possible treatment for life-threatening peanut allergy with the appointment of its new CEO. ProTA has appointed former Mesoblast Vice President Operations Dr. Suzanne Lipe,…

Opthea Successfully Completes Placement and Institutional Entitlement Offer

• Placement and Institutional Entitlement Offer successfully completed, raising approximately A$42million with strong support from both existing and new institutional and sophisticated investors • Retail Entitlement Offer will open on Monday, 10 April 2017 and closes at 5:00pm…

Bionic Vision Technologies raises $US18m from State Path Capital, China Huarong

The Australian university-owned company in the race to develop a bionic eye to restore sight has been saved from its own near plunge into darkness after raising $US18 million ($23.6 million) from Chinese investors including the nephew of Hong…

The Medical Technologies and Pharmaceuticals (MTP) Roadmap – unlocking future growth opportunities for Australia

A changing global landscape The global MTP industry is on the cusp of enormous growth globally due to a range of factors including ageing populations, the growth of emerging markets seeking better health services and unprecedented innovation in…

New abilities to enhance cancer research at the Australian Synchrotron

It gave me great pleasure to today unveil the newest research tool that Australian scientists and researchers have in the fight against cancer. The Australian Synchrotron’s new multi-million dollar Australian Cancer Research Foundation (ACRF) Detector will fast-track new…

Opthea Launches A$45 Million Financing to Progress OPT- 302 Expanded Clinical Development

Opthea Limited (ASX:OPT) (“Opthea”), a developer of novel biologic therapies for the treatment of eye diseases, today announced the launch of an entitlement offer and institutional placement (collectively the “Offer”) to raise approximately A$45 million. Proceeds from the…

Home

News & opinion

Member Directory

Events